Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life

Toxicology

Volumn 308, Issue , 2013, Pages 96-103

  Tien, Lu Tai ^a   Kaizaki, Asuka ^b   Pang, Yi ^c   Cai, Zhengwei ^c   Bhatt, Abhay J ^c   Fan, Lir Wan ^c  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b SHOWA UNIVERSITY   (Japan)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Synuclein; Dopamine transporter; Lipopolysaccharide; Neurodegenerative disorder; Rotenone; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE TRANSPORTER; LIPOPOLYSACCHARIDE; PESTICIDE; ROTENONE; SODIUM CHLORIDE; TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG INFUSION; MITOCHONDRION; NEUROTOXICITY; NEWBORN PERIOD; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; SUBSTANTIA NIGRA; SYNAPTOSOME;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, NEWBORN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIPOPOLYSACCHARIDES; MALE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SUBSTANTIA NIGRA;

EID: 84877118559     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.03.014     Document Type: Article

References (51)

1. Ahmadi F.A., Grammatopoulos T.N., Poczobutt A.M., Jones S.M., Snell L.D., Das M., Zawada W.M. Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis. Neurochem. Res. 2008, 33:886-901.
2. Bilbo S.D., Rudy J.W., Watkins L.R., Maier S.F. A behavioural characterization of neonatal infection-facilitated memory impairment in adult rats. Behav. Brain Res. 2006, 169:39-47.
3. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 2009, 3:14.
4. Bartels A.L., Leenders K.L. Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration. Curr. Neuropharmacol. 2010, 8:62-68.
5. Burd I., Balakrishnan B., Kannan S. Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am. J. Reprod. Immunol. 2012, 67:287-294.
6. Cai Z., Fan L.W., Kaizaki A., Tien L.T., Ma T., Pang Y., Lin S., Lin R.C.S., Simpson K.L. Neonatal systemic exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Dev. Neurosci. 2013, 10.1159/000346156.
7. Cai Z., Pang Y., Lin S., Rhodes P.G. Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res. 2003, 975:37-47.
8. Chae S.W., Kang B.Y., Hwang O., Choi H.J. Cyclooxygenase-2 is involved in oxidative damage and alpha-synuclein accumulation in dopaminergic cells. Neurosci. Lett. 2008, 436:205-209.
9. Champy P., Höglinger G.U., Féger J., Gleye C., Hocquemiller R., Laurens A., Guérineau V., Laprévote O., Medja F., Lombès A., Michel P.P., Lannuzel A., Hirsch E.C., Ruberg M. Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. J. Neurochem. 2004, 88:63-69.
10. Chen Y.R., Chen C.L., Zhang L., Green-Church K.B., Zweier J.L. Superoxide generation from mitochondrial NADH dehydrogenase induces self-inactivation with specific protein radical formation. J. Biol. Chem. 2005, 280:37339-37348.
11. Chinta S.J., Mallajosyula J.K., Rane A., Andersen J.K. Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett. 2010, 486:235-239.
12. Cumming P., Borghammer P. Molecular imaging and the neuropathologies of Parkinson's disease. Curr. Top. Behav. Neurosci. 2012, 11:117-148.
13. Danzer K.M., Haasen D., Karow A.R., Moussaud S., Habeck M., Giese A., Kretzschmar H., Hengerer B., Kostka M. Different species of α-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 2007, 27:9220-9232.
14. Desplats P., Lee H.J., Bae E.J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13010-13015.
15. El-Agnaf O.M., Salem S.A., Paleologou K.E., Cooper L.J., Fullwood N.J., Gibson M.J., Curran M.D., Court J.A., Mann D.M., Ikeda S., Cookson M.R., Hardy J., Allsop D. Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 2003, 17:1945-1947.
16. El-Agnaf O.M., Salem S.A., Paleologou K.E., Curran M.D., Gibson M.J., Court J.A., Schlossmacher M.G., Allsop D. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 2006, 20:419-425.
17. Fan L.W., Chen R.F., Mitchell H.J., Lin R.C.S., Simpson K.L., Rhodes P.G., Cai Z. α-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats. J. Neurosci. Res. 2008, 86.:3536-3547.
18. Fan L.W., Mirchell H.J., Rhodes P.G., Cai Z. Alpha-phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced neuronal injury in the neonatal rat brain. Neuroscience 2008, 151:737-744.
19. Fan L.W., Mirchell H.J., Tien L.T., Zheng B., Pang Y., Rhodes P.G., Cai Z. Alpha-phenyl-n-tert-butyl-nitrone reduces lipopolysaccharide-induced white matter injury in the neonatal rat brain. Dev. Neurol. 2008, 68:365-378.
20. Fan L.W., Pang Y., Lin S., Rhodes P.G., Cai Z. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 2005, 133:159-168.
21. Fan L.W., Pang Y., Lin S., Tien L.T., Ma T., Rhodes P.G., Cai Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J. Neurosci. Res. 2005, 82:71-82.
22. Fan L.W., Tien L.T., Lin R.C.S., Simpson K.L., Rhodes P.G., Cai Z. Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Neurobiol. Dis. 2011, 44:304-316.
23. Fan L.W., Tien L.T., Zheng B., Pang Y., Lin R.C.S., Simpson K.L., Ma T., Rhodes P.G., Cai Z. Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. Brain Behav. Immun. 2011, 25:286-297.
24. Feleder C., Tseng K.Y., Calhoon G.G., O'Donnell P. Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats. Biol. Psychiatry 2010, 67:386-392.
25. Fleming S.M., Zhu C., Fernagut P.O., Mehta A., Dicarlo C.D., Seaman R.L., Xhesselet M.F. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp. Neurol. 2004, 187:418-429.
26. Gao H.M., Zhang F., Zhou H., Kam W., Wilson B., Hong J.S. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ. Health Perspect. 2011, 119:807-814.
27. Hadlock G.C., Baucum A.J., King J.L., Horner K.A., Cook G.A., Gibb J.W., Wilkins D.G., Hanson G.R., Fleckenstein A.E. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. J. Pharmacol. Exp. Ther. 2009, 329:169-174.
28. Hoglinger G.U., Lannuzel A., Khondiker M.E., Michel P.P., Duyckaerts C., Feger J., Champy P., Prigent A., Medja F., Lombes A., Oertel W.H., Ruberg M., Hirsch E.C. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J. Neurochem. 2005, 95:930-939.
29. Landrigan P.J., Sonawane B., Butler R.N., Transande L., Callan R., Droller D. Early environmental origins of neurodegenerative disease in later life. Environ. Health Perspect. 2005, 113:1230-1233.
30. Lee H.J., Suk J.E., Bae E.J., Lee S.J. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem. Biophys. Res. Commun. 2008, 372:423-428.
31. Lin C.H., Huang J.Y., Ching C.H., Chuang J.I. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats. J. Pineal Res. 2008, 44:205-213.
32. Ling Z., Chang Q.A., Tong C.W., Leurgans S.E., Lipton J.W., Carvey P.M. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp. Neurol. 2004, 190:373-383.
33. Ling Z., Gayle D.A., Ma S.Y., Lipton J.W., Tong C.W., Hong J.S., Carvey P.M. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord. 2002, 17:116-124.
34. Ling Z., Zhu Y., Tong C., Snyder J.A., Lipton J.W., Carvey P.M. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp. Neurol. 2006, 199:499-512.
35. 3H]dopamine uptake into rat striatal synaptosomes. Biochem. Pharmacol. 2002, 63:1499-1505.
36. Miller D.B., O'Callaghan J.P. Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?. Metabolism 2008, 57(Suppl. 2):S44-S49.
37. Nickell J.R., Krishnamurthy S., Norrholm S., Deaciuc G., Siripurapu K.B., Zheng G., Crooks P.A., Dwoskin L.P. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2. J. Pharmacol. Exp. Ther. 2010, 332:612-621.
38. Pacheco C., Aguayo L.G., Opazo C. An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain. Front. Physiol. 2012, 3:297.
39. Pang Y., Cai Z., Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res. Dev. Brain Res. 2003, 140:205-214.
40. Sai Y., Wu Q., Le W., Ye F., Li Y., Dong Z. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Toxicol. In Vitro 2008, 22:1461-1468.
41. Sanchez-Guajardo V., Febbraro F., Kirik D., Romero-Ramos M. Microglia acquire distinct activation profiles depending on the degree of a-synuclein neuropathology in a rAAV based model of Parkinson's disease. PLoS ONE 2010, 5:e8784.
42. Schallert T., Woodlee M.T. Motor systems: orienting and placing. The Behaviour of the Laboratory Rat: A Handbook with Tests 2005, 129-140. Oxford University Press, New York. I.Q. Whishaw, B. Kolb (Eds.).
43. Schapira A.H. Mitochondrial pathology in Parkinson's disease. Mt. Sinai J. Med. 2011, 78:872-881.
44. Sherer T.B., Kim J.H., Betarbet R., Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 2003, 179:9-16.
45. Sidhu A., Wersinger C., Vernier P. Alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Lett. 2004, 565:1-5.
46. Sidhu A., Wersinger C., Vernier P. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?. FASEB J. 2004, 18:637-647.
47. Sierks M.R., Chatterjee G., McGraw C., Kasturirangan S., Schulz P., Prasad S. CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease. Integr. Biol. (Camb.) 2011, 3:1188-1196.
48. Tillerson J.L., Cohen A.D., Caudle W.M., Zigmond M.J., Schallert T., Miller G.W. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J. Neurosci. 2002, 22:6790-6799.
49. Uversky V.N. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 2004, 318:225-241.
50. Woodlee M.T., Asseo-garcia A.M., Zhao X., Liu S.J., Jones T.A., Schallert T. Testing forelimb placing across the midline reveals distinct, lesion-dependent patterns of recovery in rats. Exp. Neurol. 2005, 191:310-317.
51. Zhang W., Wang T., Pei Z., Miller D.S., Wu X., Block M.L., Wilson B., Zhang W., Zhou Y., Hong J.S., Zhang J. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 2005, 19:533-542.